Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON61781Not yet recruiting
Randomised, double-blind trial of methylphenidate, estradiol and progesterone (4 arms), sponsored by Leiden University. Primary endpoints: Error-related negativity, Reward-related positivity and 5 more. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON61781.